Taken together, our study not only revealed the important role of XIST/miR-181a/PTEN signaling pathway in HCC pathogenesis, but also implied a potential role for both miR-181a and XIST in the clinical diagnosis and treatment of HCC. The gene discussed is XIST; the disease is hepatocellular carcinoma.